Press release
Global Human Chorionic Gonadotropin Market Projected to Grow at 8.2% CAGR, Reaching $1.41 Billion by 2029
Human Chorionic Gonadotropin
What Will the Human Chorionic Gonadotropin Industry Market Size Be by 2025?
The market encompassing human chorionic gonadotropin has experienced robust expansion recently, projected to increase its valuation from $0.95 billion in 2024 to $1.02 billion in 2025, reflecting an 8.4% compound annual growth rate. This upward trajectory during the past period stems from several factors, including the heightened incidence of hypogonadism observed within the aging demographic, heightened consciousness regarding HCG among both medical practitioners and the general public, the growing appeal of fertility travel, an expanding elderly population base, and better healthcare infrastructure coupled with enhanced financial accessibility to medical services.
What's the Long-Term Growth Forecast for the Human Chorionic Gonadotropin Market Size Through 2029?
Anticipation surrounds the human chorionic gonadotropin sector, projecting substantial expansion in the forthcoming years, with its market valuation projected to reach $1.41 billion by 2029, fueled by an annual average growth rate (CAGR) of 8.2%; this upswing is primarily driven by a greater occurrence of infertility issues globally, the escalating spread of polycystic ovary* syndrome, the rise in female fertility challenges, and the heightened application of HCG within the realm of veterinary pharmaceuticals, while key developments shaping this period involve progress in identifying pregnancy early, the creation of novel medicinal preparations, the incorporation of new technologies, greater emphasis placed on research endeavors, and continuous product novelty.
View the full report here:
https://www.thebusinessresearchcompany.com/report/human-chorionic-gonadotropin-global-market-report
What Are the Key Growth Drivers Fueling the Human Chorionic Gonadotropin Market Expansion?
The escalating incidence of infertility is anticipated to be the impetus behind the expansion of the human chorionic gonadotropin market moving ahead. Infertility is characterized by the failure to achieve pregnancy following a minimum of twelve months involving regular, unprotected sexual activity. This rising infertility trend is linked to various contributors, including a tendency toward later parenthood, shifts in daily living patterns, exposure to environmental elements, and underlying health issues faced by growing numbers of individuals and couples struggling with conception. Human chorionic gonadotropin (hCG) plays a role in fertility therapies by triggering egg release in females and bolstering testosterone creation in males, thereby aiding the discharge of ova and enhancing the likelihood of successful conception. To illustrate the scale of this issue, data shared by the World Health Organization, an international body headquartered in Switzerland, indicated in April 2023 that approximately 17.5 percent of adults globally, equating to about one in every six persons, were impacted by infertility, underscoring the significant requirement for enhanced availability of affordable, quality reproductive healthcare for those requiring it; consequently, the mounting global infertility rates are fueling the expansion observed in the human chorionic gonadotropin market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18638&type=smp
What Are the Key Trends Driving Human Chorionic Gonadotropin Market Growth?
Leading entities within the human chorionic gonadotropin sector are concentrating efforts on the creation of novel merchandise, notably pregnancy detection kits, aiming to boost the precision of diagnoses, elevate results for patients, and broaden their presence across the market. These kits serve as instruments to ascertain pregnancy status by identifying human chorionic gonadotropin (hCG) within the body. A specific illustration involves Proov, an American manufacturer of medical apparatus, which, in June 2022, released advanced hCG tests engineered for prompt pregnancy identification, allowing females to confirm gestation as early as six days before a missed menstrual cycle; these diagnostic tools operate by recognizing hCG presence in urine and boast a superior reliability exceeding 99 percent, thereby furnishing women with an easily obtained and trustworthy means to ascertain their pregnancy condition sooner than conventional methods permit, thus facilitating proactive choices about their reproductive well-being.
How Is the Human Chorionic Gonadotropin Market Segmented?
The human chorionic gonadotropinmarket covered in this report is segmented -
1) By Technology: Natural Source Extraction; Recombinant Technology
2) By Therapeutic Area: Female Infertility Treatment; Oligospermic Treatment; Male Hypogonadism; Other Therapeutic Areas
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End User: Fertility Clinics; Research Institutions; Other End Users
Subsegments:
1) By Natural Source Extraction: Extraction From Pregnant Women's Urine; Extraction From Animal Sources
2) By Recombinant Technology: Recombinant Hcg; Recombinant Hcg For Therapeutic Use; Recombinant Hcg For Diagnostic Applications
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=18638&type=smp
Which Companies Are Leading the Charge in Human Chorionic Gonadotropin Market Innovation?
Major companies operating in the human chorionic gonadotropin market are Pfizer Inc., Merck & Co Inc., Novartis AG, Bristol-Myers Squibb Company, Fresenius Kabi AG, Janssen Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Limited, Menarini Group, Cipla Limited, Hikma Pharmaceuticals plc, Ferring Pharmaceuticals Inc., Intas Pharmaceuticals Ltd., Zydus Lifesciences Limited, Lupin Limited, Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Scripps Laboratories Inc., Aspen Pharmacare Holdings Limited, Corona Remedies Pvt Ltd., Sanzyme Private Limited, Biocare Medical LLC, Lee BioSolutions Inc., MyBioSource Inc.
Which Regions Are Leading the Global Human Chorionic Gonadotropin Market in Revenue?
North America was the largest region in the human chorionic gonadotropin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human chorionic gonadotropin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18638
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Human Chorionic Gonadotropin Market Projected to Grow at 8.2% CAGR, Reaching $1.41 Billion by 2029 here
News-ID: 4277328 • Views: …
More Releases from The Business Research Company
Key Industry Players Strengthening Their Position In The Direct Coombs Test (DCT …
The Direct Coombs Test (DCT) antibody market is gaining significant traction as advancements in medical diagnostics and growing healthcare needs drive demand. With innovations enhancing testing accuracy and expanding applications across diverse medical fields, this market is set to experience substantial growth in the upcoming years. Let's explore the market's projected size, key players, trends shaping the industry, and how the market is segmented.
Direct Coombs Test (DCT) Antibody Market Size…
Global Trends Analysis: How The Dental Practice Analytics Dashboards Market Is R …
The dental practice analytics dashboards market is on track for significant expansion in the coming years, driven by the increasing use of data and technology in dental care management. As dental practices seek more efficient and patient-centered solutions, this market is set to grow rapidly, with new innovations and partnerships further enhancing its potential.
Projected Market Size and Growth for Dental Practice Analytics Dashboards
The market for dental practice analytics dashboards is…
Datacenters Market Structure, Emerging Trends, And Leading Player Insights
The datacenters market is on the verge of remarkable growth as digital transformation accelerates across multiple industries. Driven by cutting-edge technologies and changing business needs, this sector is set to expand rapidly in the coming years. Let's explore the current market size, the main companies involved, emerging trends, and the key segments shaping the future of datacenters globally.
Steady Growth Forecast for the Datacenters Market by 2029
The global datacenters market is…
Key Industry Players Strengthening Their Position In The Contract Food Service M …
The contract food service management sector is on track for notable expansion as consumer preferences and operational models evolve. Driven by rising health consciousness and technological advancements, this market is adapting to meet new demands while exploring innovative solutions. Let's delve into the current market size, key players, emerging trends, and major segments shaping the industry's future.
Projected Market Value and Growth Dynamics in the Contract Food Service Management Market
The contract…
More Releases for Human
Mooka: Replacing Human Error with AI - Not Human Connection
Salt Lake City, UT - October 21, 2025 - In an era where automation and artificial intelligence are reshaping nearly every corner of online retail, Mooka [https://www.mooka.io/], a leader in eCommerce automation and marketplace optimization, is taking a clear stand: AI should replace human error, not human interaction.
As eCommerce continues to scale, many sellers face a growing challenge-how to keep operations efficient while preserving the human touch that builds trust,…
Tennessee United for Human Rights Challenging Hate this Human Rights Day
Nashville, Tennessee, 10th October 2025, ZEX PR WIRE, Tennessee United for Human Rights (TNUHR) coordinates with human rights agencies across the state to organize the annual Human Rights Day celebration, set for December 10, 2025, in Nashville, Tennessee.
This year's theme, "Challenging Hate: Standing Together for Universal Human Rights," reflects the ongoing commitment of local organizations to unite communities, confront prejudice, and promote equality and understanding for all.
The celebration will honor…
Global Human Augmentation Market 2024-2031: Advancing Human Potential Through Te …
Global Human Augmentation Market reached US$ 252.6 Billion in 2023 and is expected to reach US$ 780.7 Billion by 2031, growing with a CAGR of 15.6% during the forecast period 2024-2031.
The Human Augmentation Market focuses on technologies enhancing human capabilities through wearable exoskeletons, neural interfaces, prosthetics, and performance-enhancing devices. Growth is fueled by medical rehabilitation, industrial automation, defense applications, and lifestyle technology. Advances in robotics, AI, and brain-computer interfaces expand…
Human Factors and Usability Engineering Services Market Key Players Analysis - H …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Human Factors and Usability Engineering Services Market"-, By Steps Involved (Summative Study, Contextual Analysis, Formative Study, Known Use Error Analysis, Use Risk Analysis, Submission Preparation, Design Process and Task Analysis), By Type of Research Method (Evaluation Research and Generative Research), Class of Medical Device Tested (Class I, Class II and Class III ), Industry Trends, and…
Defending Human Life
Albert Covarrubias, Jr was fighting for his Constitutional rights and was killed in the line of duty by his own police force. There is no divine right to kill him for simply standing up for his rights. Every person has the right to stand for what they believe, rather than be gunned down. You cannot take away human life as being ok with simply saying it was a mistake.
If someone…
I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern…
